Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1995 Jan;86(1):48–56. doi: 10.1111/j.1349-7006.1995.tb02987.x

Localization of Urokinase‐type Plasminogen Activator, Plasminogen Activator Inhibitor‐1, 2 and Plasminogen in Colon Cancer

Hiroyuki Naitoh 1, Yutaka Eguchi 1,✉, Hisao Ueyama 2, Masashi Kodama 1, Takanori Hattori 3
PMCID: PMC5920580  PMID: 7737909

Abstract

We examined the localization of urokinase‐type plasminogen activator (u‐PA), plasminogen activator inhibitors (PAI‐1 and PAI‐2) and plasminogen (plg) in 26 cases of colon cancer by immunohistochemical staining. The u‐PA antigen was detected in the cytoplasm of cancer cells (18/26) and stromal cells adjacent to cancer tissues (9/26). The localization of u‐PA mRNA examined by in situ hybridization was consistent with that of u‐PA antigen. The PAI‐1 antigen was detected in fibroblasts and endothelial cells (22/26), while PAI‐2 antigen was found in cancer cells (20/26). The plg antigen was seen in the extracellular matrix of the cancer stroma. The u‐PA expression in cancer cells was significantly more frequently detected in cases with lymph node metastasis than in cases without metastasis. In either PAI‐1‐ or PAI‐2‐expressing cases, lymph node metastasis seemed to be restrained. These findings indicate that cancer cells themselves produce u‐PA, and suggest that u‐PA converts plg into plasmin, which dissolves the extracellular matrix surrounding cancer cells, resulting in cancer invasion and metastasis. PAI‐1 and PAI‐2 may have inhibitory actions on cancer invasion and metastasis mediated by u‐PA.

Keywords: Plasminogen activator, Plasminogen activator inhibitor, In situ, hybridization, Colon cancer, Immunohistochemistry

Full Text

The Full Text of this article is available as a PDF (1.4 MB).

REFERENCES

  • 1. ) Nakajima , M. and Chop , A. M.Tumor invasion and extracellular matrix degradative enzymes: regulation of activity by organ factors . Semin. Cancer Biol. , 2 , 115 – 127 ( 1991. ). [PubMed] [Google Scholar]
  • 2. ) Tryggvason , K. , Höyhtyä , M. and Salo , T.Proteolytic degradation of extracellular matrix in tumor invasion . Biochim. Biophys. Acta , 907 , 191 – 217 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Liotta , L. A. , Steeg , P. S. and Stetler‐Stevenson , W. G.Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation . Cell , 64 , 327 – 336 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Danø , K. , Andreasen , P. A. , Grøndahl‐Hansen , J. , Kristensen , P. , Nielsen , L. S. and Skriver , L.Plasminogen activators, tissue degradation and cancer . Adv. Cancer Res. , 44 , 139 – 266 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Blasi , F. , Vassalli , J. D. and Danø , K.Urokinase‐type plasminogen activator: proenzyme, receptor, and inhibitors . J. Cell Biol. , 104 , 801 – 805 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. ) Corasanti , J. G. , Celik , C. , Camiolo , S. M. , Mittelman , A. , Evers , J. L. , Barbasch , A. , Hobica , G. H. and Markus , G.Plasminogen activator content of human colon tumors and normal mucosae: separation of enzymes and partial purification . J. Natl. Cancer Inst. , 65 , 345 – 351 ( 1980. ). [PubMed] [Google Scholar]
  • 7. ) de Bruin , P. A. F. , Verspaget , H. W. , Griffioen , G. , Nap , M. , Verheijen , J. H. and Lamers , C. B. W. H.Plasminogen activator activity and composition in human colorectal carcinomas . Fibrinolysis , 1 , 57 – 62 ( 1987. ). [Google Scholar]
  • 8. ) Sim , P. S. , Stephens , R. W. , Fayle , D. R. H. and Doe , W. F.Urokinase‐type plasminogen activator in colorectal carcinomas and adenomatous polyps: quantitative expression of active and proenzyme . Int. J. Cancer , 42 , 483 – 488 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 9. ) Cajot , J. F. , Bamat , J. , Bergonzelli , G. E. , Kruithof , E. K. O. , Medcalf , R. L. , Testuz , J. and Sordat , B.Plasminogen‐activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells . Proc. Natl. Acad. Sci. USA , 87 , 6939 – 6943 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. ) Montgomery , A. M. P. , De Clerck , Y. A. , Langley , K. E. , Reisfeld , R. A. and Mueller , B. M.Melanoma‐mediated dissolution of extracellular matrix: contribution of urokinase‐dependent and metalloproteinase‐dependent proteolytic pathways . Cancer Res. , 53 , 693 – 700 ( 1993. ). [PubMed] [Google Scholar]
  • 11. ) Laug , W. E. , Cao , X. R. , Yu , Y. B. , Shimada , H. and Kruithof , E. K.Inhibition of invasion of HT1080 sarcoma cells expressing recombinant plasminogen activator inhibitor 2 . Cancer Res. , 53 , 6051 – 6057 ( 1993. ). [PubMed] [Google Scholar]
  • 12. ) Riccio , A. , Grimaldi , G. , Verde , P. , Sebastio , G. , Boast , S. and Blasi , F.The human urokinase‐plasminogen activator gene and its promoter . Nucleic Acids Res. , 13 , 2759 – 2771 ( 1985. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. ) Hölyke , H. J. and Kessler , C.Non‐radioactive labeling of RNA transcripts in vitro with the hapten digoxigenin (DIG); hybridization and ELISA‐based detection . Nucleic Acids Res. , 18 , 5843 – 5851 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. ) Lion , T. and Haas , O. A.Nonradioactive labeling of probe with digoxigenin by polymerase chain reaction . Anal. Biochem. , 188 , 335 – 337 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Springer , J. E. , Robbins , E. , Gwag , B. J. , Lewis , M. E. and Baldino , F. J.Non‐radioactive detection of nerve growth factor receptor (NGFR) mRNA in rat brain using in situ hybridization histochemistry . J. Histochem. Cytochem. , 39 , 231 – 234 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Quax , P. H. A. , van Leeuwen , T. J. , Verspaget , H. W. and Verheijen , J. H.Protein and messenger RNA levels of plasminogen activators and inhibitors analyzed in 22 human tumor cell lines . Cancer Res. , 50 , 1488 – 1494 ( 1990. ). [PubMed] [Google Scholar]
  • 17. ) Markus , G. , Camiolo , S. M. , Kohga , S. , Madeja , J. M. and Mittleman , A.Plasminogen activator secretion of human tumors in shortterm organ culture, including a comparison of primary and metastatic colon tumors . Cancer Res. , 43 , 5517 – 5525 ( 1983. ). [PubMed] [Google Scholar]
  • 18. ) Kohga , S. , Harvey , S. R. , Weaver , R. M. and Markus , G.Localization of plasminogen activators in human colon cancer by immunoperoxidase staining . Cancer Res. , 45 , 1787 – 1796 ( 1985. ). [PubMed] [Google Scholar]
  • 19. ) Sier , C. F. M. , Fellbaum , C. , Verspaget , H. W. , Schmitt , M. , Griffioen , G. , Graeff , H. , Höfler , H. and Lamers , C. B. H. W.Immunolocalization of urokinase‐type plasminogen activator in adenomas and carcinomas of the colorectum . Histopathology , 19 , 231 – 237 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Grøndahl‐Hansen , J. , Ralfkiær , E. , Kirkeby , L. T. , Kristensen , P. , Lund , L. R. and Danø , K.Localization of urokinase‐type plasminogen activator in stromal cells in adenocarcinomas of colon in humans . Am. J. Pathol. , 138 , 111 – 117 ( 1991. ). [PMC free article] [PubMed] [Google Scholar]
  • 21. ) Huber , K. , Kirchheimer , C. , Sedlmayer , A. , Bell , C. , Ermler , D. and Binder , B. R.Clinical value of determination of urokinase‐type plasminogen activator antigen in plasma for detection of colorectal cancer: comparison with circulating tumor‐associated antigens CA19‐9 and carcinoembryonic antigen . Cancer Res. , 53 , 1788 – 1793 ( 1993. ). [PubMed] [Google Scholar]
  • 22. ) Cubellis , M. V. , Wun , T. C. and Blasi , F.Receptor‐mediated internalization and degradation of urokinase is caused by its specific inhibitor PAI‐1 . EMBO J. , 9 , 1079 – 1085 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. ) Jensen , P. H. , Christensen , E. I. , Ebbesen , P. , Gliemann , J. and Andreasen , P. A.Lysosomal degradation of receptor‐bound urokinase‐type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells . Cell Regul. , 1 , 1043 – 1056 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. ) Uhl , J. , Newton , R. C. , Gross , J. L. , Rommi , W. and Mochan , E.Modulation of synovial fibroblast plasminogen activator and plasminogen activator inhibitor production by protein kinase C . Biochim. Biophys. Acta , 1097 , 283 – 288 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Pepper , M. S. , Belin , D. , Montesano , R. , Orci , L. and Vassalli , J. D.Transforming growth factor‐beta 1 modulates basic flbroblast growth factor‐induced proteolytic and angiogenic properties of endothelial cells in vitro . J. Cell Biol. , 111 , 743 – 755 ( 1990. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. ) Rifkin , D. B. and Moscatelli , D.Recent developments in the cell biology of basic fibroblast growth factor . J. Cell Biol. , 109 , 1 – 6 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. ) Takahashi , K. , Kwaan , H. C. , Ikeo , K. and Koh , E.Phosphorylation of a surface receptor bound urokinase‐type plasminogen activator in a human metastatic carcinomatous cell line . Biochem. Biophys. Res. Commun. , 182 , 1466 – 1472 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Takahashi , K. , Kwaan , H. C. , Koh , E. and Tanabe , M.Enzymatic properties of the phosphorylated urokinase‐type plasminogen activator isolated from a human carcinomatous cell line . Biochem. Biophys. Res. Commun. , 182 , 1473 – 1481 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 29. ) Rabbani , S. A. , Desjardins , J. , Bell , A. W. , Banville , D. , Mazar , A. , Henkin , J. and Goltzman , D.An amino‐terminal fragment of urokinase isolated from a prostate cancer cell line (PC‐3) is mitogenic for osteoblast‐like cells . Biochem. Biophys. Res. Commun. , 173 , 1058 – 1064 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 30. ) Reilly , D. , Christensen , L. , Duch , M. , Nolan , N. , Duffy , M. J. and Andereasen , P. A.Type‐1 plasminogen activator inhibitor in human breast carcinomas . Int. J. Cancer , 50 , 208 – 214 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 31. ) Pyke , C. , Kristensen , P. , Ralfkiær , E. , Eriksen , J. and Danø , K.The plasminogen activation system in human colon cancer: messenger RNA for the inhibitor PAI‐1 is located in endothelial cells in tumor stroma . Cancer Res. , 51 , 4067 – 4071 ( 1991. ). [PubMed] [Google Scholar]
  • 32. ) Pyke , C. , Ralfkiær , E. , Huhtala , P. , Hurskainen , T. , Danø , K. and Tryggvason , K.Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization . Cancer Res. , 52 , 1336 – 1341 ( 1992. ). [PubMed] [Google Scholar]
  • 33. ) Basset , P. , Bellocq , J. P. , Wolf , C. , Stoll , I. , Hutin , P. , Limacher , J. M. , Podhajcer , O. L. , Chenard , M. P. , Rio , M. C. and Chambon , P.A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas . Nature , 348 , 699 – 704 ( 1990. ). [DOI] [PubMed] [Google Scholar]
  • 34. ) Nakamura , M. , Konno , H. , Tanaka , T. , Maruo , Y. , Nishino , N. , Aoki , K. , Baba , S. , Sakaguchi , S. , Takada , Y. and Takada , A.Possible role of plasminogen activator inhibitor 2 in the prevention of the metastasis of gastric cancer tissues . Thromb. Res. , 65 , 709 – 719 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 35. ) Sumiyoshi , K. , Serizawa , K. , Urano , T. , Takada , Y. , Takada , A. and Baba , S.Plasminogen activator system in human breast cancer . Int. J. Cancer , 50 , 345 – 348 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 36. ) Gleeson , N. C. , Gonsalves , R. and Bonnar , J.Plasminogen activator inhibitors in endometrial adenocarcinoma . Cancer , 72 , 1670 – 1672 ( 1993. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES